Amylin Pharmaceuticals to Webcast Third Quarter Results
October 11 2007 - 4:05PM
PR Newswire (US)
SAN DIEGO, Oct. 11 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (NASDAQ:AMLN) will webcast its Quarterly
Update Conference Call for the third quarter of 2007 on Wednesday,
October 17, 2007 at 5:00 p.m. ET/2:00 p.m. PT. Daniel M. Bradbury,
Amylin's President and Chief Executive Officer, will lead the call.
On the same date post market, Amylin will release financial results
for the third quarter of 2007. The call will be webcast live
through Amylin's corporate website and a recording will be made
available following the close of the call. To access the webcast,
please log on to http://www.amylin.com/ approximately fifteen
minutes prior to the call to register, download and install any
necessary audio software. For those without access to the Internet,
the live call may be accessed by phone by calling (866) 700-6979
(domestic) or (617) 213-8836 (international), passcode 48312438. A
replay of the call will also be available by phone for 24 hours
beginning approximately one hour after the close of the call and
can be accessed at (888) 286-8010 (domestic) or (617) 801-6888
(international), passcode 10940869. About Amylin Pharmaceuticals,
Inc. Amylin Pharmaceuticals, Inc. is a biopharmaceutical company
committed to improving lives through the discovery, development and
commercialization of innovative medicines. Amylin has developed and
gained approval for two first-in-class medicines for diabetes,
SYMLIN(R) (pramlintide acetate) injection and BYETTA(R) (exenatide)
injection. Amylin's research and development activities leverage
the company's expertise in metabolism to develop potential
therapies to treat diabetes and obesity. Amylin is located in San
Diego, California with over 1,800 employees nationwide. Further
information on Amylin Pharmaceuticals is available at
http://www.amylin.com/. DATASOURCE: Amylin Pharmaceuticals, Inc.
CONTACT: Alice Bahner Izzo, Executive Director, Corporate Affairs
of Amylin Pharmaceuticals, Inc., +1-858-552-2200, ext. 7272 Web
site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024